“In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies.” Mitrović et al (2014).
Mitrović, Z., Komljenović, I., Prka, Z,, Crnek, S.S., Stojsavljević, R.A., Haris, V., Kusec, R., Dautovic, D. and Pejsa, V. (2014) The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies–a single center experience. Lijec̆nic̆ki Vjesnik. 136(5-6), p.136-40. .
Peripherally inserted central catheters in patients with haematological malignancies http://ctt.ec/vIGQj+ @ivteam #ivteam
AIM: In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies.
METHODS: In the period from 2009 to 2012, a total of 105 PICCs were inserted in 90 patients. Patients with Non-Hodgkin lymphoma treated with DA-EPOCH comprised almost 40% of the cohort.
RESULTS: The total PICC in-dwell time was 14781 days with a median of 129 days (range 8-570 days). Malposition of the PICC occurred in 12 patients (11.4%) with a successful reposition or re-insertion. In 39 patients (37%) PICC was removed before the end of treatment due to suspected or proven infection (30 patients, 29%; 2.03 per 1000 PICC days), thrombosis associated with PICC in four patients (3.8%), occlusion of the PICC (two patients), misplaced catheter (two patients), and suspected thromboembolism in a single patient.
CONCLUSION: PICC is a safe and convenient long-term venous access in patients with hematological malignancies.
Thank you to our partners for supporting IVTEAM